New hope for tough blood cancers: oral combo therapy trial
NCT ID NCT04655755
Summary
This study is testing a new combination of three oral cancer drugs for people with high-risk forms of two blood cancers (MDS and CMML) who haven't had treatment before. The first part aims to find the safest dose, and the second part measures how well the combination works to control the disease. The goal is to see if this oral regimen can help patients achieve remission and reduce their need for blood transfusions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.